Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Novolimus Eluting Coronary Stent System
Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 15 Feb 2019
At a glance
- Drugs Novolimus (Primary)
- Indications Myocardial ischaemia
- Focus Therapeutic Use
- Sponsors Elixir Medical Corporation
- 15 Feb 2019 Last check against ClinicalTrials.gov: US National Institutes of Health
- 06 Feb 2019 Planned End Date changed from 1 Apr 2021 to 31 Dec 2021.
- 06 Feb 2019 Status changed from recruiting to active, no longer recruiting.